Cite
A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance.
MLA
Das, Subhayan, et al. “A Novel Computational Predictive Biological Approach Distinguishes Integrin Β1 as a Salient Biomarker for Breast Cancer Chemoresistance.” BBA: Molecular Basis of Disease, vol. 1869, no. 6, Aug. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bbadis.2023.166702.
APA
Das, S., Kundu, M., Hassan, A., Parekh, A., Jena, B. C., Mundre, S., Banerjee, I., Yetirajam, R., Das, C. K., Pradhan, A. K., Das, S. K., Emdad, L., Mitra, P., Fisher, P. B., & Mandal, M. (2023). A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance. BBA: Molecular Basis of Disease, 1869(6), N.PAG. https://doi.org/10.1016/j.bbadis.2023.166702
Chicago
Das, Subhayan, Moumita Kundu, Atif Hassan, Aditya Parekh, Bikash Ch. Jena, Swati Mundre, Indranil Banerjee, et al. 2023. “A Novel Computational Predictive Biological Approach Distinguishes Integrin Β1 as a Salient Biomarker for Breast Cancer Chemoresistance.” BBA: Molecular Basis of Disease 1869 (6): N.PAG. doi:10.1016/j.bbadis.2023.166702.